Connor, Clark & Lunn Investment Management (CC&L)’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $23K | Sell |
|
|||||
|
2021
Q3 | $287K | Sell |
|
|||||
|
2021
Q2 | $473K | Sell |
|
|||||
|
2021
Q1 | $461K | Buy |
|
|||||
|
2020
Q4 | $328K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $340K | Sell |
|
|||||
|
2018
Q3 | $1.35M | Buy |
|
|||||
|
2018
Q2 | $1.12M | Buy |
|
|||||
|
2018
Q1 | $233K | Buy |
|
|||||
|
2017
Q4 | $657K | Buy |
|
|||||
|
2017
Q3 | $232K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $574K | Buy |
|